Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Filings indexed 354 across all filing types
Latest filing 2023-03-03 Proxy Solicitation & In…
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Boryung Corporation. It contains the meeting agenda, details on voting procedures (including electronic voting), and management's reference materials for the meeting, such as financial statements and board activity reports. This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the upcoming AGM and request their votes.
2023-03-03 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the Financial Supervisory Service) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting date, agenda items (such as approval of financial statements and director compensation), and instructions for electronic voting. While it contains financial data, the primary purpose is proxy solicitation for the AGM, making it a Proxy Solicitation & Information Statement.
2023-03-03 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Boryung. It outlines the date, location, and agenda items (such as financial statement approval and director compensation) for the upcoming meeting. This type of document is a standard proxy solicitation/notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-02-20 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Boryung regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) perfectly.
2023-02-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Change in Sales or Profit/Loss Structure of 30% or more'. This is a standard preliminary earnings announcement (often referred to as a 'preliminary results' or 'provisional earnings' filing) in the Korean market. It provides key financial highlights (revenue, operating profit, net income) for the fiscal year compared to the previous year, explicitly stating these are preliminary figures subject to audit. This fits the definition of an Earnings Release (ER) as it is the initial announcement of periodical financial results. FY 2022
2023-02-06 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Disclosure' (영업(잠정)실적) from Boryung, which provides key financial highlights (revenue, operating profit, net income) for the 4th quarter of 2022. It is a concise announcement of financial results rather than a full report, fitting the definition of an Earnings Release (ER). Q4 2022
2023-02-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.